However, the contribution and the frequency of BRCA1 mutations in individuals with TNBC, not specifically selected for age at diagnosis or enriched family history of breast/ovarian cancer, are not investigated in the Tunisian population and are to be established. This evidence concerns the gene BRCA1 and neoplasm.